Tumor necrosis factor-alpha induced expression of matrix metalloproteinase-9 through p21-activated Kinase-1

Tumor necrosis factor-alpha induced expression of matrix metalloproteinase-9 through p21-activated Kinase-1

<p>Abstract</p> <p>Background</p> <p>Expressed in embryonic development, matrix metalloprotein-9 (MMP-9) is absent in most of developed adult tissues, but recurs in inflammation during tissue injury, wound healing, tumor formation and metastasis. Expression of MMP-9 is...

Full description

Bibliographic Details
Main Authors:	Garner Warren, Kida Yujiro, Gieling Roben G, Yan Chunli, Zhou Ling, Li Wei, Han Yuan-Ping
Format:	Article
Language:	English
Published:	BMC 2009-03-01
Series:	BMC Immunology
Online Access:	http://www.biomedcentral.com/1471-2172/10/15

Similar Items

Expression of Toll-Like Receptor 4, Tumor Necrosis Factor-Alpha, Matrix Metalloproteinase-9 and Effects of Benazepril in Patients with Acute Coronary Syndromes
by: Zhi-ling Gao, et al.
Published: (2010-10-01)

Expression of Toll-Like Receptor 4, Tumor Necrosis Factor-Alpha, Matrix Metalloproteinase-9 and Effects of Benazepril in Patients with Acute Coronary Syndromes
by: Ping Xie, et al.
Published: (2010-01-01)

Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
by: Wei, S, et al.
Published: (2005)

Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview.
by: Chandler, S, et al.
Published: (1997)

The Role of Tumor Necrosis Factor  (TNF ) and Matrix Metalloproteinase9 (MMP9) Serum in Preterm Premature Rupture of Membranes
by: Ardiles Ardiles, et al.
Published: (2017-12-01)

Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy.
by: Brennan, F, et al.
Published: (1997)

Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-alpha (TNF-alpha) production suggest the major TNF-alpha converting enzyme is not an MMP.
by: Black, R, et al.
Published: (1996)

Expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in recurrent chronic rhinosinusitis with nasal polyposis
by: Ling-Feng Wang, et al.
Published: (2013-01-01)

Hypoxia Inducible Factor-1 Alpha and Matrix Metalloproteinase-9 in Dysfunctional Uterine Bleeding
by: Ketki Khandhadiya, et al.
Published: (2022-06-01)

Matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinases-1 in sarcoidosis patients
by: Ivanišević Jasmina, et al.
Published: (2017-01-01)

Ras, metastasis, and matrix metalloproteinase 9.
by: Bernhard, E, et al.
Published: (2001)

Role of matrix metalloproteinase 9 in pituitary tumor behavior.
by: Turner, H, et al.
Published: (2000)

The Role of Matrix Metalloproteinase9 (MMP9) in Endometriosis
by: Amalia Amalia, et al.
Published: (2017-12-01)

<it>Matrix metalloproteinase-9 </it>gene polymorphisms in nasal polyposis
by: Tai Chih-Feng, et al.
Published: (2010-06-01)

Expression of Matrix Metalloproteinase-2 and -9 in Meningioma
by: Sohail Mashayekhi, et al.
Published: (2018-01-01)

The Significance of Matrix Metalloproteinase 9 (MMP-9) and Metalloproteinase 2 (MMP-2) in Urinary Bladder Cancer
by: Jacek Kudelski, et al.
Published: (2023-03-01)

Diverse Impact of N-Acetylcysteine or Alpha-Lipoic Acid Supplementation during High-Fat Diet Regime on Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 in Visceral and Subcutaneous Adipose Tissue
by: Marta Wołosowicz, et al.
Published: (2022-04-01)

The content of matrix metalloproteinase-1, -9 and tissue inhibitor of matrix metalloproteinase-1 in patients with bronchial asthma and obesity
by: V. V. Kachkovska, et al.
Published: (2023-12-01)

Correlation of matrix metalloproteinase 3 and matrix metalloproteinase 9 levels with non-motor symptoms in patients with Parkinson’s disease
by: Chuan Ze Liu, et al.
Published: (2022-08-01)

Variants of the <it>Matrix Metalloproteinase-2 </it>but not the <it>Matrix Metalloproteinase-9 </it>genes significantly influence functional outcome after stroke
by: Sobral João, et al.
Published: (2010-03-01)

Plasma matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 as prognostic biomarkers in critically ill patients
by: Duda Izabela, et al.
Published: (2020-03-01)

Expression of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Endometriosis Menstrual Blood
by: Tita Husnitawati Madjid, et al.
Published: (2020-06-01)

Matrix metalloproteinase-9 in patients with acute coronary syndrome.
by: Lee, R
Published: (2012)

Pathophysiological Role of Chymase-Activated Matrix Metalloproteinase-9
by: Shinji Takai, et al.
Published: (2022-10-01)

Asthma remodeling: The pathogenic role of matrix metalloproteinase-9
by: Amgad A. Farhat, et al.
Published: (2014-10-01)

Matrix Metalloproteinase-9 as an Important Contributor to the Pathophysiology of Depression
by: Hongmin Li, et al.
Published: (2022-03-01)

Immunohistochemical expression of matrix metalloproteinase -9 in invasive meningioma
by: Samar U. Hasan*, et al.
Published: (2021-07-01)

Expression of matrix metalloproteinase-9 and protein KI-67 at prostate tumors
by: M I Andrukhin, et al.
Published: (2014-12-01)

Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment
by: Zainab Ahmed Rashid, et al.
Published: (2023-07-01)

Immunohistochemical characterization of the expression of matrix metalloproteinase - 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in the invasive endometrioid endometrial carcinoma
by: A. V. Chepets
Published: (2015-12-01)

Interplay between matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in acute asthma exacerbation and airway remodeling
by: Ghada Mahmoud Mohamed, et al.
Published: (2012-07-01)

The regulation of trophoblast invasion and decidual reaction by matrix metalloproteinase‐2, metalloproteinase‐7, and metalloproteinase‐9 expressions in the rat endometrium
by: Rasim Hamutoğlu, et al.
Published: (2020-10-01)

Procyanidins attenuate neuropathic pain by suppressing matrix metalloproteinase-9/2
by: Cailong Pan, et al.
Published: (2018-06-01)

Clinical significance of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 and 2 in Kawasaki disease
by: Ki Wook Yun, et al.
Published: (2010-04-01)

Gene polymorphisms of cyclin‐dependent kinase inhibitor and matrix metalloproteinase‐9 in Sudanese patients with esophageal squamous cell carcinoma
by: Majdolin Mohammed Eltayeb, et al.
Published: (2022-12-01)

Body composition and serum levels of matrix metalloproteinase-9, adiponectin and AMP-activated protein kinase in breast cancer survivors
by: Zeinab Babaei, et al.
Published: (2022-01-01)

Downregulation of CD9 in keratinocyte contributes to cell migration via upregulation of matrix metalloproteinase-9.
by: Xu-pin Jiang, et al.
Published: (2013-01-01)

Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients
by: A. O. Rubanenko, et al.
Published: (2018-11-01)

Matrix Metalloproteinases
by: S Sahitya, et al.
Published: (2010-01-01)

Tumor Necrosis Factor-α, Matrix-Metalloproteinases 8 and 9 Levels in the Saliva Are Associated with Increased Hemoglobin A1c in Type 1 Diabetes Subjects.
by: Melanie N Kuehl, et al.
Published: (2015-01-01)